ATE557032T1 - Verfahren zur erzeugung von zwischenprodukten zur herstellung neuer makrocyclen als inhibitoren der proteasomischen degradation von p27 wie argyrin und derivate davon sowie verwendung dieser makrocyclen - Google Patents

Verfahren zur erzeugung von zwischenprodukten zur herstellung neuer makrocyclen als inhibitoren der proteasomischen degradation von p27 wie argyrin und derivate davon sowie verwendung dieser makrocyclen

Info

Publication number
ATE557032T1
ATE557032T1 AT09797415T AT09797415T ATE557032T1 AT E557032 T1 ATE557032 T1 AT E557032T1 AT 09797415 T AT09797415 T AT 09797415T AT 09797415 T AT09797415 T AT 09797415T AT E557032 T1 ATE557032 T1 AT E557032T1
Authority
AT
Austria
Prior art keywords
macrocycles
inhibitors
derivatives
argyrine
production
Prior art date
Application number
AT09797415T
Other languages
English (en)
Inventor
Markus Kalesse
Nisar Malek
Ronald Frank
Tobias Brodmann
Leila Buelow
Andreas Rentsch
Anna-Katharina Girbig
Ulrike Eggert
Original Assignee
Helmholtz Infektionsforschung
Hannover Med Hochschule
Univ Hannover
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Infektionsforschung, Hannover Med Hochschule, Univ Hannover filed Critical Helmholtz Infektionsforschung
Application granted granted Critical
Publication of ATE557032T1 publication Critical patent/ATE557032T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT09797415T 2008-06-23 2009-06-23 Verfahren zur erzeugung von zwischenprodukten zur herstellung neuer makrocyclen als inhibitoren der proteasomischen degradation von p27 wie argyrin und derivate davon sowie verwendung dieser makrocyclen ATE557032T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08011346A EP2138507A1 (de) 2008-06-23 2008-06-23 Verfahren zur Erzeugung von Zwischenprodukten zur Herstellung von neuartigen Makrozyklen als Inhibitoren der proteasomischen Degradation von p27 wie Argyrin und Derivate davon, und Verwendungen besagter Makrozyklen
PCT/EP2009/004526 WO2010006682A1 (en) 2008-06-23 2009-06-23 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles

Publications (1)

Publication Number Publication Date
ATE557032T1 true ATE557032T1 (de) 2012-05-15

Family

ID=39957997

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09797415T ATE557032T1 (de) 2008-06-23 2009-06-23 Verfahren zur erzeugung von zwischenprodukten zur herstellung neuer makrocyclen als inhibitoren der proteasomischen degradation von p27 wie argyrin und derivate davon sowie verwendung dieser makrocyclen

Country Status (8)

Country Link
US (1) US9458200B2 (de)
EP (2) EP2138507A1 (de)
JP (1) JP5634397B2 (de)
AT (1) ATE557032T1 (de)
AU (1) AU2009270571B2 (de)
CA (1) CA2729188C (de)
ES (1) ES2391220T3 (de)
WO (1) WO2010006682A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5735977B2 (ja) * 2009-12-14 2015-06-17 ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー ｐ２７のプロテアソーム分解の阻害因子である、アルギリン及びその誘導体等の大員環の製造の中間体を製造する改善された方法
US9029501B2 (en) 2010-11-02 2015-05-12 Rigel Pharmaceuticals, Inc. Method for making macrocycles
ES2682595T3 (es) * 2015-03-23 2018-09-21 Eberhard Karls Universität Tübingen Nuevo compuesto antiinfeccioso
MX2021006533A (es) * 2018-12-11 2021-07-21 Heidelberg Pharma Res Gmbh Sintesis del (s)-6-hidroxitriptofano y derivados del mismo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355774B1 (en) 1994-01-07 2002-03-12 Fred Hutchinson Cancer Research Center Isolated p27 protein
GB2367553A (en) 2000-09-04 2002-04-10 Novartis Ag Pharmaceutically Active Macrocycles
EP1352080A4 (de) 2001-01-05 2005-04-06 Univ New York Verfahren zur identifizierung von für die behandlung von proliferativen und differentiativen erkrankungen geeigneten verbindungen
EP1964560A1 (de) 2007-02-28 2008-09-03 Helmholtz-Zentrum für Infektionsforschung GmbH Verwendung von Inhibitoren des p27-Abbaus zur Behandlung von Krebs

Also Published As

Publication number Publication date
AU2009270571A1 (en) 2010-01-21
CA2729188C (en) 2017-10-24
EP2138507A1 (de) 2009-12-30
JP5634397B2 (ja) 2014-12-03
WO2010006682A1 (en) 2010-01-21
CA2729188A1 (en) 2010-01-21
JP2011525512A (ja) 2011-09-22
ES2391220T3 (es) 2012-11-22
US20110311564A1 (en) 2011-12-22
US9458200B2 (en) 2016-10-04
EP2303916A1 (de) 2011-04-06
EP2303916B1 (de) 2012-05-09
AU2009270571B2 (en) 2014-05-15

Similar Documents

Publication Publication Date Title
ATE538095T1 (de) Verfahren zur herstellung von 2-substituierten 5- (1-alkylthio)-alkylpyridinen
CY1118143T1 (el) Ετεροκυκλικες ενωσεις χρησιμες ως αναστολεις της pdk1
MX2011001679A (es) Derivados de flavina.
ATE523556T1 (de) Modifizierte polymerzusammensetzungen, modifikationsverfahren und mittel zur erzeugung freier radikale
WO2009009620A3 (en) Acellular tissue matrix compositions for tissue repair
DE502006002496D1 (de) Verfahren zur herstellung von polyurethanschichten und deren verwendung als kunstleder
MX2010013917A (es) Induccion de floculacion en organismos fotosinteticos.
ATE382049T1 (de) Neue 2-benzylaminodihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
MX2012005782A (es) Procedimientos, composiciones y kits de liofilizacion.
MX2011013117A (es) Peptidos especificos del receptor de melanocortina.
MX2009008178A (es) Uso de semaforina 6a para promover la mielinizacion y la diferenciacion de oligodendrocitos.
WO2009150547A3 (en) 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors
IN2012DN02624A (de)
ATE557032T1 (de) Verfahren zur erzeugung von zwischenprodukten zur herstellung neuer makrocyclen als inhibitoren der proteasomischen degradation von p27 wie argyrin und derivate davon sowie verwendung dieser makrocyclen
ATE516290T1 (de) Verfahren zur herstellung von buprenorphin und derivaten von buprenorphin
NO20082425L (no) Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer
GB201201753D0 (en) Therapeutic agents with improved fibrinogen binding
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
MX2009003022A (es) Composiciones y metodos para tratar picaduras de medusa.
MA32416B1 (fr) 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation
DE602007011324D1 (de) Verfahren zur herstellung von 2-substituierten 5-(1-alkylthio)alkylpyridinen
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
EA201190313A1 (ru) Замещенные пиперидины
ATE535524T1 (de) Derivate von 2-oxoalkyl-1-piperazin-2-on, verfahren zu deren herstellung und deren therapeutische verwendung
EP2294197A4 (de) Hhip1-proteinvariante sowie verfahren und verwendungen dafür